HACKETT GROUP, INC. HCKT
The Hackett Group, Inc. (NASDAQ: HCKT) is a global, IP platform-based generative artificial intelligence ("Gen AI") strategic advisory, business transformation, and enterprise application implementation firm. We combine proprietary benchmarking and best-practice process intelligence intellectual property ("IP") with Gen AI–enabled delivery platforms to help clients identify, prioritize, design, and implement high-impact improvements across enterprise functions, including supply chain and operations, finance, human resources, information technology, procurement and corporate services, as well as selected enterprise application implementation services, including Oracle, SAP, OneStream, and eProcurement applications.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- United States
- Europe (U.K., Germany, France and Switzerland)
- Other (Australia, Canada, India and Uruguay)
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| United States | $246.1M | $259.4M | $251.0M |
| Europe (U.K., Germany, France and Switzerland) | $34.3M | $35.3M | $28.6M |
| Other (Australia, Canada, India and Uruguay) | $25.3M | $19.1M | $16.9M |
As the company reported it, from the “Segment Information and Geographical Data (Geographic Revenue before Reimbursements) (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $305.6M | $313.9M | $296.6M | $293.7M | $278.8M | $239.5M | $282.5M | $285.9M | $276.6M | $279.8M |
| Cost of revenue | $188.5M | $190.6M | $180.2M | $178.2M | $173.1M | $166.4M | $185.7M | $186.3M | $183.3M | $186.2M |
| Gross profit | $117.2M | $123.2M | $84.4M | $89.5M | $83.8M | $52.4M | $96.8M | $99.6M | $93.3M | $93.6M |
| SG&A | $90.5M | $78.5M | $65.9M | $61.0M | $59.2M | $54.0M | $62.1M | $64.1M | $63.3M | $60.1M |
| Total operating expenses | $282.1M | $269.3M | $247.3M | $238.5M | $232.3M | $230.8M | $251.1M | $252.3M | $247.9M | $246.3M |
| Operating income | $23.5M | $44.6M | $49.3M | $55.2M | $46.5M | $8.6M | $31.3M | $33.6M | $28.7M | $33.5M |
| Interest expense | $1.7M | $1.6M | $3.2M | $144.0K | $95.0K | $126.0K | $311.0K | $638.0K | $584.0K | $387.0K |
| Pre-tax income | $21.8M | $43.0M | $46.0M | $55.1M | $46.4M | $8.5M | $31.0M | $32.9M | $28.1M | $33.1M |
| Income tax | $8.9M | $13.4M | $11.9M | $14.3M | $4.8M | $2.9M | $7.7M | $5.6M | $2.6M | $12.5M |
| Net income | $12.9M | $29.6M | $34.2M | $40.8M | $41.5M | $5.5M | $23.3M | $23.9M | $27.4M | $21.5M |
| EPS, basic | 0.47 | 1.08 | 1.26 | 1.30 | 1.38 | 0.18 | 0.78 | 0.81 | 0.95 | 0.74 |
| EPS, diluted | 0.46 | 1.05 | 1.24 | 1.28 | 1.26 | 0.17 | 0.72 | 0.74 | 0.85 | 0.66 |
| Shares, diluted (wtd. avg.) | 27.9M | 28.1M | 27.6M | 32.0M | 32.9M | 32.4M | 32.5M | 32.3M | 32.2M | 32.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $18.2M | $16.4M | $21.0M | $30.3M | $45.8M | $49.5M | $26.0M | $13.8M | $17.5M | $19.7M |
| Receivables | — | — | — | — | — | $32.8M | $49.8M | $54.8M | $52.3M | $47.4M |
| Total current assets | $83.9M | $76.3M | $75.4M | $81.2M | $102.2M | $84.8M | $78.6M | $73.1M | $75.3M | $68.8M |
| Property, plant and equipment | $24.0M | $20.3M | $20.0M | $19.4M | $18.0M | $18.2M | $19.9M | $19.8M | $18.9M | $14.8M |
| Goodwill | $90.7M | $89.8M | $84.2M | $83.5M | $85.1M | $85.3M | $84.6M | $84.2M | $85.1M | $72.4M |
| Other intangibles | $3.3M | $2.3M | — | — | $159.0K | $1.2M | $2.1M | $3.1M | $5.5M | $2.7M |
| Total assets | $206.4M | $193.3M | $181.4M | $185.0M | $207.5M | $192.5M | $193.7M | $180.8M | $185.2M | $159.3M |
| Accounts payable | $6.3M | $6.5M | $7.6M | $8.7M | $7.7M | $6.1M | $8.5M | $7.4M | $8.4M | $9.1M |
| Total current liabilities | $48.8M | $53.1M | $49.9M | $59.6M | $54.9M | $42.6M | $43.7M | $44.2M | $51.4M | $55.8M |
| Long-term debt | $75.8M | $12.7M | $32.7M | $59.7M | — | — | — | $6.5M | $19.0M | $7.0M |
| Total liabilities | $138.3M | $77.7M | $91.3M | $126.7M | $63.7M | $51.7M | $56.1M | $57.2M | $78.0M | $73.0M |
| Retained earnings | $78.4M | $78.3M | $60.8M | $38.6M | $11.3M | -$17.4M | -$13.7M | -$25.4M | -$38.5M | -$56.6M |
| Total equity | $68.1M | $115.6M | $90.1M | $58.3M | $143.9M | $140.9M | $137.6M | $123.6M | $107.3M | $86.3M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $40.3M | $47.7M | $37.4M | $58.9M | $46.4M | $44.1M | $42.4M | $32.4M | $26.5M | $32.9M |
| Depreciation and amortisation | $5.2M | $3.9M | $3.4M | $3.4M | $4.4M | $4.5M | $3.2M | $2.5M | $2.4M | $2.5M |
| Stock-based compensation | $10.9M | $11.8M | $10.7M | $10.3M | $10.1M | $9.7M | $7.7M | $9.3M | $10.3M | $8.8M |
| Capital expenditure | $7.9M | $4.1M | $4.1M | $4.7M | $3.2M | $1.9M | $4.6M | $9.6M | $6.5M | $3.2M |
| Investing cash flow | -$8.6M | -$10.6M | -$4.1M | -$4.7M | -$3.2M | -$1.9M | -$5.6M | -$9.6M | -$17.5M | -$3.2M |
| Financing cash flow | -$29.8M | -$41.7M | -$42.6M | -$69.7M | -$46.7M | -$18.7M | -$24.7M | -$26.6M | -$11.2M | -$33.5M |
| Dividends paid | $12.9M | $12.1M | $12.0M | $10.4M | $12.9M | $14.9M | $11.2M | $10.0M | $8.7M | $7.2M |
| Buybacks | $69.1M | $6.4M | $734.0K | $116.6M | $13.0M | $2.4M | $7.8M | $4.8M | $15.7M | $34.1M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-082863.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $279.8M | $276.6M | $285.9M | $282.5M | $239.5M | $278.8M | $293.7M | $296.6M | $313.9M | $305.6M |
| Gross profit | $93.6M | $93.3M | $99.6M | $96.8M | $52.4M | $83.8M | $89.5M | $84.4M | $123.2M | $117.2M |
| Net income | $21.5M | $27.4M | $23.9M | $23.3M | $5.5M | $41.5M | $40.8M | $34.2M | $29.6M | $12.9M |
Recent filings and events
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Results announced Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Results announced Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced Item 2.02
- Results announced Item 2.02
- Shareholder vote Item 5.07
- Annual report filed Form 10-K
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8742
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| BAH | Booz Allen Hamilton Holding Corp | $9.42B | 11.4x | -6.4% |
| G | Genpact LTD | $6.86B | 13.0x | 6.6% |
| FCN | FTI CONSULTING, INC | $4.34B | 19.1x | 2.4% |
| EXPO | EXPONENT INC | $3.68B | 37.4x | 4.2% |
| HURN | Huron Consulting Group Inc. | $3.17B | 33.5x | 11.9% |
| ASTH | Astrana Health, Inc. | $2.09B | 81.4x | 56.4% |
| ICFI | ICF International, Inc. | $1.69B | 19.1x | -7.3% |
| BWMN | Bowman Consulting Group Ltd. | $742.5M | 58.7x | 14.9% |